{
  "id": 17917961,
  "title": "LG Chem revises licensing deal with U.S. firm for obesity drug",
  "url": "https://urgent.news/2026/11/03/lg-chem-revises-licensing-deal-with-u-s-firm-for-obesity-drug",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-03T05:42:24.000Z",
  "source": {
    "name": "Yonhap News",
    "slug": "yonhap-news",
    "url": "https://en.yna.co.kr/view/AEN20261103007100320"
  },
  "original_language": "en",
  "account": null,
  "summary": "SEOUL, Nov. 3 (Yonhap) -- LG Chem Ltd., South Korea's leading chemical company, ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "The Korea Times",
        "title": "LG Chem revises licensing deal with US firm for obesity drug",
        "url": "https://urgent.news/2026/11/03/lg-chem-revises-licensing-deal-with-us-firm-for-obesity-drug",
        "published": "2026-11-03T06:07:03.000Z"
      },
      {
        "outlet": "Korea IT Times",
        "title": "LG Chem Expands Obesity Drug Licensing Deal with Rhythm Pharmaceuticals to $855 Million",
        "url": "https://urgent.news/2026/11/03/lg-chem-expands-obesity-drug-licensing-deal-with-rhythm",
        "published": "2026-11-03T06:08:52.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}